More Like This

Show all results sharing this subject:

  • Clinical Pharmacology and Therapeutics


Show Summary Details

Quick Reference

A selective irreversible monoamine oxidase B inhibitor used to treat early-stage Parkinson's disease. TNs Eldepryl, Zelapar.

Subjects: Clinical Pharmacology and Therapeutics.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.